Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02320422 · ClinicalTrials.gov registry record · NA
Adult Liver Transplant Enhanced Care
A NA study of Liver Transplant Recipients, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT02320422: Completed NA study of Liver Transplant Recipients, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02320422 is a NA study of Liver Transplant Recipients that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 8 participants, below the 90-participant average among 3 other Liver Transplant Recipients trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02320422, a NA study of Liver Transplant Recipients, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to pilot-test a tailored telemetric intervention to improve adherence to medications in adults who had a liver transplant and are presently non-adherent (as measured by tacrolimus levels).
Primary Outcome
The degree of fluctuation of tacrolimus blood levels (calculated as the standard deviation, SD, of tacrolimus).
Conditions Studied
Interventions
- BEHAVIORAL Behavioral Telehealth
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02320422 record still lists
NCT02320422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 90-participant average among 3 other Liver Transplant Recipients trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Liver Transplant Recipients appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Telehealth is the first listed.
NCT02320422 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02320422 about?
NCT02320422 is a clinical study titled "Adult Liver Transplant Enhanced Care". The purpose of this study is to pilot-test a tailored telemetric intervention to improve adherence to medications in adults who had a liver transplant and are presently non-adherent (as measured by tacrolimus levels).
What is the current status of trial NCT02320422?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-01. Estimated completion is 2016-08.
What conditions does trial NCT02320422 study?
This clinical trial studies the following conditions: Liver Transplant Recipients.
What interventions are being tested in trial NCT02320422?
The interventions under investigation include: Behavioral Telehealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT02320422?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02320422 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant Recipients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant
COMPLETED · Phase 4
-
COVID Protection After Transplant-Immunosuppression Reduction
COMPLETED · Phase 2
-
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia